• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Hepatitis Testing Markets

$2,500.00 – $5,000.00

Clear
SKU: KLI15466368 Category: Diagnostics Market Research Pages: 50
  • Description
  • Table of Contents
  • Latest reports

Description

Hepatitis Testing Markets

This report, Hepatitis Testing Markets, includes

Hepatitis Immunoassay Market, 2016 – 2021

Hepatitis Molecular Testing Market, 2016 -2021

Hepatitis Point of Care Markets, 2016-2021

Molecular Testing Market by Type (C, B, A and Others)

Key Trends in the Market

Geographic Breakout of Market (US, ROW)

Company Profiles

HCV in particular is a driver of sales in this market. While HCV infections are increasingly caught and treated among baby boomers (a fact easily observable in Medicare billings), U.S. HCV incidence is also sharply increasingly among younger generations or individuals 20-39 years of age. Intravenous drug use is again the cause of rising HCV cases in this age group as well.

Molecular diagnostics is unrivaled among the IVD technologies used for infectious disease testing in terms of its performance and applicability. Microarray, next-generation sequencing and development-stage isothermal amplification methods represent promising contributions to the market space. For the time being, PCR and isothermal amplification tests represent the bulk of the market with assay development proceeding faster than ever using genomic science tools, microfluidics, machine automation, and novel forms of results detection. Immunoassays are more often used for the initial detection of hepatitis infections, but with the increasing significance of hepatitis in healthcare and the development of sophisticated antiviral therapeutics, molecular tests are becoming just as integral to clinical hepatitis treatment.

Table of Contents

1: EXECUTIVE SUMMARY

INTRODUCTION

Figure 1-1 New Cases Hepatitis, U.S.

VIRUS TYPES

Hep A

Hep B

Hep C

Hep D

Hep E

Increased Focus on HCV

Table 1-1: New Cases, Hepatitis A, B and C – 2005 to 2014

TESTING METHODS – MOLECULAR DIAGNOSTICS

TESTING METHODS – IMMUNOASSAYS

MARKET FOR HEPATITIS TESTING

Figure 1-1: Hepatitis Testing Market, 2016 -2021

2: HEPATITIS TESTING TECHNOLOGIES AND TRENDS

Table 2-1: Selected Hepatitis Test Innovations

IMMUNOASSAYS FOR HEPATITIS

Serological antibody assays

POC Rapid Immunoassays

Enzyme Immunoassay (EIA)

Chemiluminescence immunoassay (CIA)

Recombinant immunoblot assay (RIBA)

EIA.Immunofluorescence

MOLECULAR TECHNOLOGIES

Real-Time PCR (qPCR)

Loop-Mediated Isothermal Amplification (LAMP)

3: MARKET FOR HEPATITIS DIAGNOSTICS

MARKET ANALYSIS BY PRODUCT

Immuonassay

Table 3-1: Hepatitis, Immunoassay Testing Market (United States, ROW) 2016-21

POINT OF CARE

POC Developments

Table 3-1: Hepatitis, POC Testing Market (United States, ROW) 2016-21

Molecular

Table 3-3: Molecular Hepatitis Market Breakdown 2016-2021 United States, ROW ($M)

HEPATITIS COMPETITIVE ANALYSIS

4: COMPANY PROFILES

ABBOTT DIAGNOSTICS

Table 4-1: Abbott Diagnostics Revenue (2013-2016) ($ millions)

Infectious Diseases/qPCR

BECKMAN COULTER (DANAHER)

Hep C

Hep B; A-H

BIOMÉRIEUX

Table 4-2: bioMérieux Revenue (2013-2016) ($ millions)

bioMerieux Hepatitis Tests

Molecular

Sequencing

CEPHEID (DANAHER)

Table 4-3: Cepheid Revenue (2013-2016) ($ millions)

MEDMIRA

Products

ORASURE TECHNOLOGIES

QIAGEN

Table 4-4: Qiagen Revenue (2013-2016) ($ millions)

artus

ROCHE DIAGNOSTICS

Table 4-5: Roche Diagnostics Revenue (2013-2016) ($ millions)

Molecular Diagnostics

Hepatitis Tests

SIEMENS HEALTHCARE DIAGNOSTICS

Hepatitis Tests

 

    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025

Related products

  • Placeholder image

    Clinical Diagnostics in India – Market Sector Analyses and Participant Directory

    $4,500.00 – $9,990.00
  • Placeholder image

    Clinical Diagnostics in China – Market Sector Analyses and Participant Directory

    $4,995.00 – $9,990.00
  • Placeholder image

    Worldwide Point of Care (POC): Are Decentralized Clinical Diagnostics a Cost Drain or Revenue Driver?

    $1,500.00 – $5,990.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume I: Prion Disease

    $1,496.00 – $2,992.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition (201...The Market for Library Preparation and Target Enrichment for Next-Generation...
Scroll to top